SciTech Biomed-Cancer 2024 is a virtual conference scheduled during
December 19-20, 2024. Hosting researchers, scientists, students, workshop & symposium organizers, industrialists, companies, exhibitors, sponsors, media partners, oral & poster presenters from all over the world.
Biomedical research is a broad and dynamic field focused on understanding the complex mechanisms underlying human health and disease. It encompasses a variety of disciplines, from molecular biology and genetics to pharmacology and epidemiology. By exploring how biological systems function and how they are disrupted in disease states, biomedical research aims to develop new diagnostic tools, treatments, and preventive measures. Advances in this area have led to significant breakthroughs, such as targeted therapies for chronic diseases and innovative medical technologies, ultimately improving patient outcomes and quality of life.
Cancer research, a crucial subset of biomedical research, specifically targets the prevention, diagnosis, and treatment of cancer. This field investigates the genetic, environmental, and lifestyle factors that contribute to cancer development and progression. Researchers work on identifying molecular markers for early detection, developing personalized therapies that attack cancer cells while sparing healthy tissues, and understanding resistance mechanisms to current treatments. Recent advancements in cancer research include immunotherapy, which harnesses the body's immune system to fight cancer, and precision medicine, which tailors treatment based on individual genetic profiles. These efforts are essential for moving closer to more effective and less invasive cancer care, ultimately striving to reduce the global burden of this disease.
Discussions on:
- Advances in genomics and personalized medicine
- Stem cell research and regenerative medicine
- Bioinformatics and computational biology
- Drug discovery and pharmacology
- Biomaterials and tissue engineering
- Respiratory diseases and pulmonary medicine
- Endocrinology and hormone research
- Reproductive health and fertility studies
- Aging and gerontology research
- Environmental health and toxicology
- Biochemistry and molecular biology
- Cell signaling and molecular pathways
- Epigenetics and gene regulation
- Imaging techniques in biomedical research
- Cancer biology and oncology
- Diabetes research and management
- Precision medicine and biomarker discovery
- Health disparities and social determinants of health
- Public health policy and health economics
- Clinical trials and regulatory affairs
- Artificial intelligence in healthcare
- Synthetic biology and genetic engineering
- Environmental toxicology and pollution control
- Oncogenes and tumor suppressor genes
- Angiogenesis and cancer metastasis
- Cancer immunotherapy
- Targeted therapies in cancer treatment
- Precision oncology
- Biomarkers for cancer diagnosis and prognosis
- Liquid biopsies for cancer detection
- Epigenetics in cancer development
- Role of inflammation in cancer
- Cancer genomics and transcriptomics
- Immunogenomics in cancer immunotherapy
- Radiation therapy and its mechanisms of action
- Chemotherapy and drug resistance in cancer
- Radioimmunotherapy for cancer treatment
- Immunomodulatory agents in cancer therapy
- Cancer vaccines and their development
- Liquid biopsy for monitoring treatment response
- Circulating tumor cells and their significance
- Computational modeling of cancer progression
- Cancer disparities and healthcare access
- Survivorship and quality of life in cancer patients
- Palliative care and end-of-life issues
- Cancer epidemiology and population studies
- Environmental carcinogens and cancer prevention
- Pediatric oncology and childhood cancer research
- Geriatric oncology and cancer in the elderly
- Rare cancers and orphan drug development
- Artificial intelligence for early cancer detection
- Patient-reported outcomes in cancer research
- Cancer survivorship and long-term effects of treatment
